Though most breast cancers are detected by mammography before symptoms appear, common signs of breast cancer include palpable breast mass, nipple changes and regional lymphadenopathy. Breast cancer ...
Face2Face Africa on MSN
‘This is rare!’ Elite athlete and breast cancer survivor shares story after shock diagnosis at 26
At just 26, LaShae D. Rolle, MDH, CPH, received the shocking, life-altering diagnosis of HR+, HER2-, node-positive early breast cancer in October 2023. This diagnosis came with a high probability of ...
Dr. Sara M. Tolaney breaks down key takeaways from the DESTINY-Breast09 trial that patients with HER2+ advanced or metastatic breast cancer should know. Treatment with first-line Enhertu ...
—Building on earlier findings, researchers sought to determine rates of neoadjuvant systemic therapy (NST) among U.S. women with cT1–2 N0 M0 HER2-positive breast cancer, plus identify factors ...
How to navigate an early-in-life breast cancer diagnosis, from fertility concerns to career questions: What the research ...
Marty Willis' inspiring journey battling HER2-positive breast cancer during the pandemic highlights the importance of early ...
The U.S. Food and Drug Administration (FDA) has granted priority review and breakthrough therapy designation to the ...
Ziihera is the first HER2-targeted therapy given conditional authorization for HER2-positive BTC in the European Union (EU). Continued approval for this indication is contingent upon verification and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback